Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q3 EPS by 26c

Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) reported Q3 EPS of ($0.96), $0.26 better than the analyst estimate of ($1.22).

For earnings history and earnings-related data on Zentalis Pharmaceuticals, Inc. (ZNTL) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue
• Linde (LIN) PT Lowered to $563 at Bernstein SocGen Group